Evidence mapPaperPMID 35268040Full record

Trial reportNutrients2022

Reducing Metabolic Syndrome through a Group Educational Intervention Program in Adults with Obesity: IGOBE Program.

Cristina Tejera, Cristina Porca, Gemma Rodriguez-Carnero, Paula Andújar, Felipe F Casanueva, Diego Bellido, Ana B Crujeiras

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Cristina TejeraDivision of Endocrinology and Nutrition, Complejo Hospitalario Universitario de Ferrol (CHUF/ SERGAS), 15405 Ferrol, Spain.
Cristina PorcaDivision of Endocrinology and Nutrition, Complejo Hospitalario Universitario de Ferrol (CHUF/ SERGAS), 15405 Ferrol, Spain.ORCID 0000-0003-1612-6751
Gemma Rodriguez-CarneroEpigenomics in Endocrinology and Nutrition Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Complejo Hospitalario Univeristario de Santiago de Compostela (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.
Paula AndújarDivision of Endocrinology and Nutrition, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.
Felipe F CasanuevaMolecular Endocrinology Group, Instituto de Investigacion Sanitaria de Santiago (IDIS), Complejo Hospitalario Universitario de Santiago de Compostela (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-9052-8161
Diego BellidoDivision of Endocrinology and Nutrition, Complejo Hospitalario Universitario de Ferrol (CHUF/ SERGAS), 15405 Ferrol, Spain.ORCID 0000-0003-0631-2710
Ana B CrujeirasEpigenomics in Endocrinology and Nutrition Group, Instituto de Investigación Sanitaria de Santiago (IDIS), Complejo Hospitalario Univeristario de Santiago de Compostela (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-4392-0301
Complejo Hospitalario Universitario de Santiago · ESInstituto de Investigación Sanitaria de Santiago · ESCentro de Investigación Biomédica en Red · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS) increases the risk of cardiovascular disease, type 2 diabetes mellitus, and cancer. Despite the higher prevalence of MetS in obese adults, little is known about the effectiveness of intensive and group interventions in improving MetS prevalence. This study aimed to investigate the effectiveness of an intensive lifestyle program in reducing the prevalence of MetS in adults with obesity. Patients with obesity (n = 456, 48.8 ± 12.8 years, 18.5% male) were randomized in two groups as indicated in a prospective interventional real-life study: a control group (CG), in which patients received usual care, and an interventional group (IG), in which the patients participate in a healthy lifestyle habits program in six weekly sessions, IGOBE program. Anthropometric, body composition, medications, and MetS features data were analyzed in both groups at the pre-intervention and post-intervention stages using a completer’s analysis. At 12 months of follow-up, the IG showed a relative reduction of 13.4% in the prevalence of MetS from baseline, while the CG showed a reduction of 2.1% (p < 0.001). A significant reduction was also observed in four of five MetS features. In this trial, implementation of the IGOBE program resulted in a significant reduction in MetS prevalence and better control of MetS features compared with the standard of care.

Indexed as

Diabetes Mellitus, Type 2Metabolic SyndromeAdultBehavior TherapyFemaleHumansMaleObesityProspective Studiesbehavioral groupmetabolic syndromeobesityweight loss

Identifiers

PMID35268040
PMCPMC8912562
OpenAlexW4214841566

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.